✦ LIBER ✦

Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole

✍ Scribed by Jeffrey N Joyce; Steve Presgraves; Lynn Renish; Sabinne Borwege; Tracy Osredkar; Diane Hagner; Maria Replogle; Mateo PazSoldan; Mark J Millan

Book ID: 117101064
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 870 KB
Volume: 184
Category: Article
ISSN: 0014-4886
DOI: 10.1016/s0014-4886(03)00353-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Involvement of dopamine D2/D3 receptors

Involvement of dopamine D2/D3 receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells

✍ Steve P. Presgraves; Sabine Borwege; Mark J. Millan; Jeffrey N. Joyce 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 640 KB

Additive neuroprotective effects of crea

Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson’s disease

✍ Peter Klivenyi; Gabrielle Gardian; Noel Y. Calingasan; Lichuan Yang; M. Flint Be 📂 Article 📅 2003 🏛 Humana Press Inc 🌐 English ⚖ 450 KB

MAGNA CARTAThe Great CharterPreamble

📂 Fiction 🌐 English ⚖ 11 KB 👁 18 views